American Epilepsy Society — Fenfluramine, part of the weight loss combination drug Fen-Phen that was withdrawn from the market in 1997 at the request of the FDA amid concerns linking the drug to severe heart valve damage, may have anti-seizure effects in people with Dravet syndrome, a type of epilepsy. |
No comments:
Post a Comment